Health horizons

With over 200 participants from 13 countries, more than 25 speakers, four round tables, two interviews with the European Commission and the OECD, and three group sessions, the first edition of this conference was a resounding success. It provided an opportunity to address some of the hot topics in the healthcare sector, such as investment strategies and financing needs, the impact of technological advances on the sector, and key sustainability issues.

For the second edition, we will discuss M&A trends in the sector, financing strategies, priority areas for investors, artificial intelligence, the impact of the new US federal administration, and many other topics.

Speakers include:

• Prof. Agnès Buzyn, MD, PhD, former Minister of Social Affairs and Health, President of the Evidences Institute
• Jerry Randall, CEO, Venture Life Group
• Michele Perrino, CEO, Demetra / Tecres
• Sanjay Panchal, Partner, Livingbridge
• John Pissanos, Managing Director, Healthcare Investment Banking, JP Morgan
• Mathias Desmarais, Head of PE Equities, Oddo BHF
• André Choulika, CEO, Cellectis
• David Caumartin, CEO, rebrAIn
• Henry Capper, MD and Head of EMEA Biopharma, JPMorgan
• Florian Hermessan, Investment Manager, Global Real Assets at UBS
• Ian Murchie, Head of Healthcare and VC Coverage, Barclays
• Ailbhe Earley, VP France and Southern Europe, IDA Ireland